Pityriasis Rubra Pilaris Responding Rapidly to Adalimumab
Authors:
- Hobart W. WallingHWHobart W. Walling
- Brian L. SwickBSBrian L. Swick
- 1 January 2009
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 145 (1) , 99-101
Abstract
Pityriasis rubra pilaris (PRP) is an uncommon papulosquamous eruption of uncertain cause. The disease is typically indolent and recalcitrant to treatment and soKeywords
This publication has 5 references indexed in Scilit:
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2008
- Successful use of etanercept in type I pityriasis rubra pilarisBritish Journal of Dermatology, 2007
- Infliximab for the Treatment of Adult-Onset Pityriasis Rubra PilarisArchives of Dermatology, 2005
- Transient eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilarisClinical and Experimental Dermatology, 2004
- Adult pityriasis rubra pilaris: A 10-year case seriesJournal of the American Academy of Dermatology, 1997